The gathered in vivo and in vitro findings from the current study consistently unraveled that the downregulation of HDAC1 by either shRNA or JSL-1 (inhibitor of Class I HDACs) could potentially prevent the initiation and progression of CC via suppression of Snail/TPX2. Here, TPX2 is linked to cholangiocarcinoma.